These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4754650)

  • 41. [Comparison of clinical effects of minocycline and demethylchlor-tetracycline in the dermatological field].
    Minami K; Tashiro M
    Jpn J Antibiot; 1969 Dec; 22(6):493-500. PubMed ID: 4245625
    [No Abstract]   [Full Text] [Related]  

  • 42. Letter: Activity of minocycline against Bacteroids fragilis.
    Leigh DA; Simmons K
    Lancet; 1975 Jan; 1(7897):51. PubMed ID: 46948
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of subinhibitory doses of 7-dimethylamino-6-deoxy-6-demethyltetracycline on coagulase activities by Staphylococcus aureus strains sensitive to this antibiotic and resistant to alpha-6-deoxy-5-oxytetracycline (author's transl).
    Thaller MC; Pezzi R; Chiarini F
    Antibiotica; 1973; 11(3-4):134-46. PubMed ID: 4806490
    [No Abstract]   [Full Text] [Related]  

  • 44. [Application of minocycline to urinary tract infections].
    Ishigami J; Hara S; Mita T
    Jpn J Antibiot; 1969 Dec; 22(6):501-6. PubMed ID: 4909973
    [No Abstract]   [Full Text] [Related]  

  • 45. [Basic and clinical evaluations of minocycline in the pediatric field].
    Fujii R; Konno M; Okada K; Yatsumori K; Ubukata K
    Jpn J Antibiot; 1969 Dec; 22(6):451-7. PubMed ID: 5309768
    [No Abstract]   [Full Text] [Related]  

  • 46. Minocycline sensitivity related to the phage type of multiply resistant staphylococci.
    Rich G; Davidson J
    J Clin Pathol; 1975 Jun; 28(6):450-2. PubMed ID: 1040627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of minocycline, a new tetracycline.
    Fedorko J; Katz S; Allnoch H
    Am J Med Sci; 1968 Apr; 255():252-8. PubMed ID: 4385129
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sensitivity range of gram-negative microorganisms and mycoplasms to minocycline in vitro].
    Schmid E; Price P; Krech U
    Arzneimittelforschung; 1974 Sep; 24(9):1256-8. PubMed ID: 4373015
    [No Abstract]   [Full Text] [Related]  

  • 49. Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing.
    Barry AL; Draper DL; Wong MK
    Am J Clin Pathol; 1978 Nov; 70(5):821-5. PubMed ID: 717289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tigecyclin--the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline.
    Felmingham D
    J Chemother; 2005 Aug; 17 Suppl 1():5-11. PubMed ID: 16285353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Minocycline].
    Miura Y; Mizumoto T; Shibaki H
    Jpn J Antibiot; 1969 Dec; 22(6):483-7. PubMed ID: 4245623
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of minocycline on Candida albicans.
    Waterworth PM
    J Clin Pathol; 1974 Apr; 27(4):269-72. PubMed ID: 4212409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Laboratory and clinical studies on minocycline].
    Miki F; Azuma T; Iwasaki T; Akao M; Ozaki T
    Jpn J Antibiot; 1969 Dec; 22(6):445-50. PubMed ID: 4986128
    [No Abstract]   [Full Text] [Related]  

  • 54. [Current drug resistance of staphylococcus aureus].
    Pulverer G; Damen G
    Med Klin; 1972 Apr; 67(17):608-14. PubMed ID: 4483128
    [No Abstract]   [Full Text] [Related]  

  • 55. Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers.
    Devine LF; Hannah JM; Hagerman CR; Rhode SL; Peckinpaugh RO
    Mil Med; 1973 Jan; 138(1):20-4. PubMed ID: 4630051
    [No Abstract]   [Full Text] [Related]  

  • 56. Minocycline-induced activation of tetracycline-responsive promoter.
    Chtarto A; Tenenbaum L; Velu T; Brotchi J; Levivier M; Blum D
    Neurosci Lett; 2003 Dec; 352(3):155-8. PubMed ID: 14625008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activities of daptomycin, tigecycline, linezolid and eight other antibiotics, alone and in combination, against 41 Staphylococcus spp. clinical isolates from bone and joint infections.
    Kuli B; de Barbeyrac B; Dauchy FA; Dutronc H; Bébéar C; Mégraud F; Dupon M
    Int J Antimicrob Agents; 2009 May; 33(5):491-3. PubMed ID: 19153031
    [No Abstract]   [Full Text] [Related]  

  • 58. Susceptibilities of Pseudomonas species to tetracycline, minocycline, gentamicin, and tobramycin.
    Tilton RC; Steingrimsson O; Ryan RW
    Am J Clin Pathol; 1978 Apr; 69(4):410-3. PubMed ID: 645640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Laboratory and clinical studies on minocycline].
    Ito H; Obata Y; Soda T; Nagura H; Nakajima T
    Jpn J Antibiot; 1969 Dec; 22(6):541-5. PubMed ID: 4986131
    [No Abstract]   [Full Text] [Related]  

  • 60. Trends of antibiotic-resistance of Staphylococcus aureus in Germany.
    Pulverer G
    Contrib Microbiol Immunol; 1973; 1():603-13. PubMed ID: 4499259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.